Analyst Research

Report Title Price
Provider: S&P Capital IQ Quantitative Report
$127.00
Provider: Pechala's Reports
$15.00
Provider: Pechala's Reports
$25.00
Provider: Reuters Investment Profile
$20.00

NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.

AEterna Zentaris Inc Announces Closing Of $16.5 Million Public Offering Of Common Shares And Warrants


Wednesday, 17 Oct 2012 09:24am EDT 

AEterna Zentaris Inc announced the closing of its previously announced public offering of 6.6 million units (the Offering) generating net proceeds of $15.2 million, with each unit consisting of one common share and 0.45 of a warrant to purchase one common share, at a purchase price of $2.50 per unit. Each warrant is exercisable for a period of five years at an exercise price of $3.45 per share. Roth Capital Partners, LLC, acted as the sole managerfor the Offering. The Company intends to use the net proceeds from the Offering to continue to fund its ongoing drug development activities, particularly for the continued development of perifosine in multiple myeloma and the advancement of its AEZS-108 and AEZS-130 programs, as well as for general corporate purposes and working capital. 

Company Quote

1.25
0.02 +1.63%
11 Jul 2014